Search - tctmd.com

Displaying 681 - 700 of 3109

Sort: Relevancy | Date

Heart Failure, Hope, and the Hurdles Ahead for Xenotransplantation

News Opinion Off Script

Heart Failure, Hope, and the Hurdles Ahead for Xenotransplantation

Charles C. Hong, MD, PhD

February 04, 2022

Results From First-In-Human Clinical Trial of RP-A501 (AAV9:LAMP2B) Gene Therapy Treatment for Danon Disease

Presentation THT 2022

Results From First-In-Human Clinical Trial of RP-A501 (AAV9:LAMP2B) Gene Therapy Treatment for Danon Disease

Presenter: Barry Greenberg

February 01, 2022

SCAI SHOCK: Update Refines Cardiogenic Shock Classification

News Daily News

SCAI SHOCK: Update Refines Cardiogenic Shock Classification

January 31, 2022

COVID-19: TCTMD’s Dispatch for February Week 1

News Daily News

COVID-19: TCTMD’s Dispatch for February Week 1

January 31, 2022

‘Considerable’ Aortic Stenosis Burden in UK Begs Money and a Plan

News Daily News

‘Considerable’ Aortic Stenosis Burden in UK Begs Money and a Plan

Michael O'Riordan

January 28, 2022

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

News Daily News

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Michael O'Riordan

January 27, 2022

Realistic Expectations Emerge After Initial Excitement Over Xenotransplant

News Features

Realistic Expectations Emerge After Initial Excitement Over Xenotransplant

Yael L. Maxwell

January 21, 2022

DOACs Should Be Standard to Prevent VTE Recurrence in Cancer: Meta-analysis

News Daily News

DOACs Should Be Standard to Prevent VTE Recurrence in Cancer: Meta-analysis

January 20, 2022

COVID-19: TCTMD’s Dispatch for January Week 3

News Daily News

COVID-19: TCTMD’s Dispatch for January Week 3

January 17, 2022

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

News Features

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

Michael O'Riordan

January 17, 2022

Shorter Anticoagulation an Option for Young Patients With Provoked VTE

News Daily News

Shorter Anticoagulation an Option for Young Patients With Provoked VTE

January 11, 2022

January 2022 News Roundup

News Opinion CV Team Dispatch

January 2022 News Roundup

January 01, 2022

MICHELLE Published: Low-Dose Rivaroxaban Cuts VTE Risk After COVID-19 Admission

News Daily News

MICHELLE Published: Low-Dose Rivaroxaban Cuts VTE Risk After COVID-19 Admission

December 29, 2021

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

News Daily News

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

December 28, 2021

Another Win for Guided P2Y12 Therapy in ACS: Meta-analysis

News Daily News

Another Win for Guided P2Y12 Therapy in ACS: Meta-analysis

Yael L. Maxwell

December 24, 2021

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

News Features

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Michael O'Riordan

December 23, 2021

PASCAL Pinpoints Patients With Strokes Causally Related to PFO

News Daily News

PASCAL Pinpoints Patients With Strokes Causally Related to PFO

Yael L. Maxwell

December 20, 2021

As COVID-19 Drags on, the Cardiology Fallout May Haunt for Years

News Features

As COVID-19 Drags on, the Cardiology Fallout May Haunt for Years

December 16, 2021

Extended DANISH Follow-up Supports ICD Benefits in Younger Nonischemic HF Patients

News Daily News

Extended DANISH Follow-up Supports ICD Benefits in Younger Nonischemic HF Patients

December 14, 2021

British Medical Groups Express Concern About Inclisiran Rollout

News Daily News

British Medical Groups Express Concern About Inclisiran Rollout

Michael O'Riordan

December 14, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.